powerful clinical research meets innovation

ASH Annual Meeting

ACT Oncology, with more than 20 years’ experience, is a biopharmaceutical development full-service, oncology specialist, providing expert, flexible and cost-effective support for North American and International development programs. Operating from headquarters in New Jersey, USA and Madrid, Spain, with regionally-based personnel throughout the USA and Europe, our dedicated team of therapeutic, scientific and analytical experts are committed to optimizing complex oncology drug research and bringing new treatments to the market rapidly and efficiently with high quality successful outcomes.

Visit us at the ASH Annual Meeting December 6-9 in San Francisco, CA. To set up a meeting with an ACT Oncology representative, please contact: Chris Ellis: chris.ellis@actoncology.com Pat Terek: pat.terek@actoncology.com

ACT Oncology offers Sponsors a wealth of experience in the management of hematology studies. We have conducted 23 programs in Multiple Myeloma, 5 in Myelodyplastic Syndrome and 5 in Lymphoma. Our strong relationships with the Multiple Myeloma Research Foundation and leading Myeloma researchers enable us to offer unparalleled support in this challenging therapeutic area.

Click here for more details